[Secondary immunological response to cryosurgery in various stages of oral cavity neoplasms]. 1982

M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio

The authors have evaluated general immunocompetence after cryosurgical treatment of 33 patients affected by oral squamous carcinoma. Patients have been divided into two groups: 17 of them were classifiable in 1st and 2nd stage and 16 of them in 3rd and 4th stages. Serum immunoglobulin levels, C3 - C4, peripheral lymphocytes, E-rosette forming cells, lymphocyte response to PHA were analyzed before a single cryotreatment 7 and 14 days after. The results indicate that immunological parameters vary in a significant way and can be constantly observed in 1st and 2nd stages, while the 3rd and 4th stages undergo no variations. Cryosurgery in the 1st and 2nd stages is able to modify, in particular, the parameters concerning cell - mediate immunity, although the phenomenon seems transitory, showing itself most on the seventh day.

UI MeSH Term Description Entries
D007121 Immunocompetence The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen. Competence, Immunologic,Immunologic Competence,Immunological Competence,Competence, Immunological
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009062 Mouth Neoplasms Tumors or cancer of the MOUTH. Cancer of Mouth,Mouth Cancer,Oral Cancer,Oral Neoplasms,Cancer of the Mouth,Neoplasms, Mouth,Neoplasms, Oral,Cancer, Mouth,Cancer, Oral,Cancers, Mouth,Cancers, Oral,Mouth Cancers,Mouth Neoplasm,Neoplasm, Mouth,Neoplasm, Oral,Oral Cancers,Oral Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D003452 Cryosurgery The use of freezing as a special surgical technique to destroy or excise tissue. Cryoablation,Cryoablations,Cryosurgeries
D005260 Female Females

Related Publications

M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
September 1974, Archives of pathology,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
January 1975, Panminerva medica,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
June 1972, Otolaryngologic clinics of North America,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
October 1982, Wiadomosci lekarskie (Warsaw, Poland : 1960),
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
January 1974, Otolaryngologia polska = The Polish otolaryngology,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
December 2022, BMJ case reports,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
April 1971, Journal of the Canadian Dental Association,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
April 1973, Archives of otolaryngology (Chicago, Ill. : 1960),
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
November 1980, Pneumonologia polska,
M Fazio, and M Airoldi, and D Camoletto, and P Cavallero, and V Mastromatteo, and L Negri, and F Pecchio
August 1979, International journal of oral surgery,
Copied contents to your clipboard!